Edition:
United States

Stellar Biotechnologies Inc (SBOT.OQ)

SBOT.OQ on NASDAQ Stock Exchange Capital Market

2.03USD
25 May 2018
Change (% chg)

$-0.17 (-7.73%)
Prev Close
$2.20
Open
$2.15
Day's High
$2.22
Day's Low
$2.01
Volume
214,992
Avg. Vol
57,097
52-wk High
$10.43
52-wk Low
$1.96

Select another date:

Tue, May 15 2018

BRIEF-Sabby Management Llc Reports 9.99 Percent Passive Stake In Stellar Biotechnologies Inc As Of May 11

* SABBY MANAGEMENT, LLC REPORTS 9.99 PERCENT PASSIVE STAKE IN STELLAR BIOTECHNOLOGIES INC AS OF MAY 11, 2018 - SEC FILING Source text - https://bit.ly/2rJNYyF Further company coverage:

BRIEF-Stellar Acquisition Reduces Extension Date Of Initial Business Combination To August 24

* STELLAR ACQUISITION III INC. ANNOUNCES INCREASE IN MONTHLY CONTRIBUTION AMOUNT TO TRUST ACCOUNT POST-EXTENSION APPROVAL AND SHORTENING OF EXTENSION DATE TO AUGUST 24, 2018 Source text for Eikon: Further company coverage:

BRIEF-Stellar Biotechnologies Announces Pricing Of $5.5 Mln Public Offering

* STELLAR BIOTECHNOLOGIES ANNOUNCES PRICING OF $5.5 MILLION PUBLIC OFFERING

BRIEF-Stellar Biotechnologies Reports Q2 Loss Per Share Of $0.90

* STELLAR BIOTECHNOLOGIES REPORTS SECOND QUARTER FINANCIAL RESULTS

BRIEF-Stellar Biotechnologies Announces One-For-Seven Reverse Split

* STELLAR BIOTECHNOLOGIES ANNOUNCES ONE-FOR-SEVEN REVERSE SPLIT

BRIEF-Stellar Biotechnologies Reports Q1 Loss Per Share $0.13

* STELLAR BIOTECHNOLOGIES REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Stellar Biotechnologies Appoints Pharma Licensing Expert To Board Of Directors

* STELLAR BIOTECHNOLOGIES APPOINTS PHARMA LICENSING EXPERT TO BOARD OF DIRECTORS Source text for Eikon: Further company coverage:

Select another date: